Table 1.
Baseline characteristics of chronic hepatitis C infected patients, by cannabis use status (before propensity matching).
| No Cannabis use | Cannabis use | p-value | |
|---|---|---|---|
| n (~weighted) | 182587 (~887,975) | 4774 (~23,371) | |
|
| |||
| Age, mean (SD) | 53.06 (14.15) | 40 (12.96) | <0.0001 |
|
| |||
| Gender | 0.3599 | ||
| Male | 53.86 | 54.60 | |
| Female | 46.14 | 45.40 | |
|
| |||
| Race | <0.0001 | ||
| White | 59.90 | 66.23 | |
| Black | 21.63 | 18.92 | |
| Hispanics | 12.74 | 10.73 | |
| Others | 5.74 | 4.12 | |
|
| |||
| Health insurance | <0.0001 | ||
| Medicare | 33.91 | 20.92 | |
| Medicaid | 30.91 | 46.10 | |
| Private | 21.00 | 12.05 | |
| Self-pay & others | 14.18 | 20.93 | |
|
| |||
| Income | <0.0001 | ||
| Lowest Quartile | 38.04 | 45.92 | |
| Second Quartile | 24.42 | 25.41 | |
| Third Quartile | 20.99 | 18.50 | |
| Highest Quartile | 16.55 | 10.17 | |
|
| |||
| Hospital region | <0.0001 | ||
| Northeast | 24.99 | 22.23 | |
| Midwest | 11.72 | 15.18 | |
| South | 39.69 | 39.21 | |
| West | 23.60 | 23.38 | |
|
| |||
| Hospital teaching status | <0.0001 | ||
| Rural | 7.06 | 10.35 | |
| Urban non-teaching | 32.71 | 33.34 | |
| Urban teaching | 60.23 | 56.31 | |
|
| |||
| Peripheral vascular disease | 2.43 | 1.05 | <0.0001 |
|
| |||
| Congestive heart failure | 6.23 | 2.59 | <0.0001 |
|
| |||
| Hypertension | 35.92 | 22.34 | <0.0001 |
|
| |||
| Chronic lung disease | 16.49 | 16.21 | 0.6303 |
|
| |||
| Valvular heart disease | 3.14 | 1.74 | <0.0001 |
|
| |||
| Cardiac arrhythmias | 10.24 | 5.29 | <0.0001 |
|
| |||
| Chronic kidney disease | 12.64 | 4.49 | <0.0001 |
|
| |||
| Cerebral vascular disease | 3.45 | 1.71 | <0.0001 |
|
| |||
| Ischemic heart disease | 8.68 | 4.77 | <0.0001 |
|
| |||
| Hypothyroidism | 7.32 | 3.65 | <0.0001 |
|
| |||
| Hyperthyroidism | 0.38 | 0.38 | 0.9553 |
|
| |||
| Other substance abuse | 15.83 | 65.38 | <0.0001 |
|
| |||
| Malignancies | 9.95 | 3.55 | <0.0001 |
|
| |||
| AIDS | 2.89 | 2.59 | 0.2394 |